Jim Simons Renaissance Technologies
AUM
$75.8B
1-Year Est. Return
50.56%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
1 Year Est. Return
+50.56%
AUM
$75.8B
AUM Growth
+$582M
(+0.77%)
Holding
4,038
Top Buys
| 1 | +$633M | |
| 2 | +$487M | |
| 3 | +$419M | |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Coca-Cola
KO
|
+$257M |
Top Sells
| 1 | +$1.36B | |
| 2 | +$900M | |
| 3 | +$583M | |
| 4 |
NVIDIA
NVDA
|
+$335M |
| 5 |
Netflix
NFLX
|
+$320M |
Sector Composition
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.8% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Dole
DOLE
$1.47B
| $12M | 0.02% |
894,100
-80,200
|
|
||
1002
Zimmer Biomet
ZBH
$18.1B
| $12M | 0.02% |
+121,800
|
|
||
1003
National Vision
EYE
$2.25B
| $12M | 0.02% |
409,600
-376,300
|
|
||
1004
Texas Capital Bancshares
TCBI
$4.26B
| $11.9M | 0.02% |
141,100
-50,200
|
|
||
1005
Okta
OKTA
$15.7B
| $11.9M | 0.02% |
129,300
-381,318
|
|
||
1006
Phillips 66
PSX
$53.2B
| $11.8M | 0.02% |
+86,950
|
|
||
1007
Varonis Systems
VRNS
$3.85B
| $11.8M | 0.02% |
205,700
-17,200
|
|
||
1008
Revolution Medicines
RVMD
$14.8B
| $11.8M | 0.02% |
253,104
+9,600
|
|
||
1009
Daktronics
DAKT
$927M
| $11.8M | 0.02% |
564,413
-30,300
|
|
||
1010
Vanguard Emerging Markets Government Bond ETF
VWOB
$5.37B
| $11.8M | 0.02% |
176,414
+35,614
|
|
||
1011
NRG Energy
NRG
$28.6B
| $11.8M | 0.02% |
72,800
-497,516
|
|
||
|
LINE
1012
Lineage Inc
LINE
$7.94B
| $11.8M | 0.02% |
304,800
+158,231
|
|
||
1013
Prosperity Bancshares
PB
$6.83B
| $11.8M | 0.02% |
177,472
-36,400
|
|
||
1014
ACM Research
ACMR
$2.42B
| $11.7M | 0.02% |
299,925
+262,925
|
|
||
1015
Fluor
FLR
$6.59B
| $11.7M | 0.02% |
278,200
-197,500
|
|
||
1016
Envista
NVST
$3.59B
| $11.7M | 0.02% |
574,465
+285,065
|
|
||
1017
RCM Technologies
RCMT
$152M
| $11.7M | 0.02% |
439,573
-13,100
|
|
||
1018
Darden Restaurants
DRI
$22B
| $11.7M | 0.02% |
61,300
+30,200
|
|
||
1019
Middlesex Water
MSEX
$979M
| $11.6M | 0.02% |
215,013
+12,100
|
|
||
1020
Lifeway Foods
LWAY
$368M
| $11.6M | 0.02% |
417,771
-18,000
|
|
||
1021
Ingredion
INGR
$7.1B
| $11.6M | 0.02% |
94,800
-46,700
|
|
||
1022
Gilat Satellite Networks
GILT
$728M
| $11.5M | 0.02% |
886,584
-108,300
|
|
||
1023
Grupo Cibest SA
CIB
$14.8B
| $11.5M | 0.02% |
221,700
-165,300
|
|
||
1024
Inspire Medical Systems
INSP
$3.44B
| $11.5M | 0.02% |
155,000
+28,200
|
|
||
1025
Algonquin Power & Utilities
AQN
$4.68B
| $11.5M | 0.02% |
2,135,192
-1,815,829
|
|